Business
Rigel to Participate in Upcoming September Investor Conferences
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and chief executive officer, and Dean Schorno, the company's chief financial officer, will participate in the following investor conferences in September:
About this update from Rigel Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif. , Aug. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez , the company's president and chief executive officer, and Dean Schorno , the company's chief financial officer, will participate in the following investor conferences in September: To access the live webcasts or archived recordings of the Cantor and H.C. Wainwright Conference presentations, visit the Investor Relations section of the company's website at www.rigel.com . Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads. About Rigel Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California . For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com . Contact for Investors & Media: Investors: Rigel Pharmaceuticals, Inc. 650.624.1232 [email protected] Media: David Rosen Argot Partners 646.461.6387 [email protected] View original content to download multimedia: https://www.prnewswire.com/news-releases/rigel-to-participate-in-upcoming-september-investor-conferences-302538238.html SOURCE Rigel Pharmaceuticals, Inc.
View stock analysis, news, and events for Rigel Pharmaceuticals, Inc.